Back to Man Group plc Man Group plc

PTGXPTGX
10 quarters

Position history for Man Group plcMan Group plc's holdings in PROTAGONIST THERAPEUTICS INC

Man Group plc previously held 0 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$133,000

Total Shares Change

-16,801

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$65.14
0
2025-Q2
Decreased
34,013
-73.5%
$1.9M0.0%$55.69
0
2025-Q1
Decreased
128,606
-18.6%
$6.2M0.0%$48.88
0
2024-Q4
Increased
157,963
+182.9%
$6.1M0.0%$38.51
44
2024-Q3
Increased
55,831
+629.3%
$2.5M0.0%$44.56
42
2024-Q2
New
7,655
-
$265,2460.0%$34.65
32
2023-Q1
Exited
0
-100.0%
$00.0%$22.49
0
2022-Q4
Increased
94,070
+17.7%
$1M0.0%$10.91
29
2022-Q3
Increased
79,935
+375.8%
$674,0000.0%$8.25
40
2022-Q2
New
16,801
-
$133,0000.0%$8.07
31

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used